Newsletter | September 14, 2020

09.14.20 -- Debunking Myths And Misconceptions About Softgels

Debunking Myths And Misconceptions About Softgels

Softgels are a popular dosage form among consumers because of their easy swallowability and quick onset of action. Pharmaceutical developers often don’t consider softgels to be the best choice for prescription drug formulations, however, instead favoring tablets and hard-shell capsules. Here, we take a look at some common myths about softgels and explore why drug developers may want to reconsider their go-to delivery methods.

Using Lipid Formulations To Enhance Bioavailability In Early Development

Lipid formulations offer an easily scalable approach that can cut timelines and considerably reduce costs during development and commercial manufacturing. To prevent delays and costly issues during the development of these molecules it is important to understand what potential mechanisms of increased absorption with lipid formulations and appropriate screening tools are available.

Are You Prepared For The Complexity Of Pediatric Drug Development?

Pediatric drug development requires a formulation designed to fit the specific needs of that patient population. Not considering these requirements early enough could add significant delays.